Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2008
08/14/2008WO2008098252A2 Vascular implants and methods of fabricating the same
08/14/2008WO2008098245A2 Nmda receptor modulation and treatments for addictive behavior
08/14/2008WO2008098196A1 Treprostinil treatment for interstitial lung disease and asthma
08/14/2008WO2008098195A2 Film comprising nitroglycerin
08/14/2008WO2008098192A2 Compositions and methods for treating neuropathy
08/14/2008WO2008098172A1 Enhancement of innate resistance to infection
08/14/2008WO2008098160A1 Antagonists of a non-selective cation channel in neural cells
08/14/2008WO2008098143A2 Antimicrobial compounds and methods of use
08/14/2008WO2008098138A1 Synthetic macrocyclic compounds for treating cancer
08/14/2008WO2008098122A2 Method for treating allergic rhinitis without adverse effects
08/14/2008WO2008098105A1 Inhibitors of akt activity
08/14/2008WO2008098104A1 Inhibitors of akt activity
08/14/2008WO2008098096A1 Anti-cytokine heterocyclic compounds
08/14/2008WO2008098077A2 Substituted alkine derivatives as anti-cancer agents
08/14/2008WO2008098058A1 Pi 3-kinase inhibitors and methods of their use
08/14/2008WO2008098027A2 Treatment of ischemic retinal conditions with memantine
08/14/2008WO2008098025A1 Arylsulfonamide compounds which modulate the cb2 receptor
08/14/2008WO2008097991A1 Pyridopyrimidinone compounds useful in treating sodium channel-mediated diseases or conditions
08/14/2008WO2008097976A1 Heterocyclic modulators of tgr5 for treatment of disease
08/14/2008WO2008097971A2 Methods for treating diseases of altered ige regulation
08/14/2008WO2008097924A2 Pharmaceutical compositions comprising dextromethorphan analogs for the treatment of neurological disorders
08/14/2008WO2008097897A2 Pharmaceutical compositions containing substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1(pai-1)
08/14/2008WO2008097861A2 MODULATION OF NEUROGENESIS WITH BIGUANIDES AND GSK3-ß AGENTS
08/14/2008WO2008097851A1 Tetracycline compositions for topical administration
08/14/2008WO2008097850A1 Tretracycline compositions for topical administration
08/14/2008WO2008097835A2 Compositions and methods for the treatment of metabolic disorders
08/14/2008WO2008097819A2 Chemical compounds
08/14/2008WO2008097796A1 Indolobenzazepine derivatives for the treatment of hepatitis c
08/14/2008WO2008097766A1 Chemical compounds, pharmaceutical compositions and methods
08/14/2008WO2008097692A1 Compounds, compositions and methods for the treatment of inflammatory diseases
08/14/2008WO2008097676A1 Compounds and compositions as channel activating protease inhibitors
08/14/2008WO2008097673A1 Compounds and compositions as channel activating protease inhibitors
08/14/2008WO2008097664A1 Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
08/14/2008WO2008097661A1 Stabilized picoplatin oral dosage form
08/14/2008WO2008097658A1 Encapsulated picoplatin
08/14/2008WO2008097654A1 Methods of using saha for treating hiv infection
08/14/2008WO2008097646A1 Methods to treat and/or prevent mucositis
08/14/2008WO2008097546A2 Compounds that inhibit cholinesterase
08/14/2008WO2008097539A2 Multi-modal absorption, medicine-delivery lozenge, and use thereof
08/14/2008WO2008097538A1 Therapeutic agents
08/14/2008WO2008097535A2 Method of treating atherosclerosis, dyslipidemias and related conditions
08/14/2008WO2008097504A2 Use of a trpm5 inhibitor to regulate insulin and glp-1 release
08/14/2008WO2008097468A2 Selective endothelin type-a antagonists
08/14/2008WO2008097364A2 Use of oritavancin for prevention and treatment of anthrax
08/14/2008WO2008097341A2 Antiviral compounds and use thereof
08/14/2008WO2008097317A1 Solvating system and sealant for medical use
08/14/2008WO2008097233A1 Stable pharmaceutical drug aerosols
08/14/2008WO2008097220A1 Olopatadine formulations for topical nasal administration
08/14/2008WO2008097180A1 New compounds, methods for their preparation and use thereof
08/14/2008WO2008097112A1 Amidinoanthracycline antibiotics for use in the treatment of viral infections
08/14/2008WO2008097066A1 An oral sustained-release triple layer tablet
08/14/2008WO2008096998A1 Use of a seeds extract of myristica fragrans or active compounds isolated therefrom for preventing or treating osteoporosis
08/14/2008WO2008096894A1 Cellulose derivative and method for production thereof
08/14/2008WO2008096870A1 Aza-bridged-ring compound
08/14/2008WO2008096841A1 Dimerized cyclo derivative
08/14/2008WO2008096829A1 Tricyclic compounds
08/14/2008WO2008096820A1 Biphenyl derivative
08/14/2008WO2008096804A1 Eye drop preparation comprising latanoprost
08/14/2008WO2008096791A1 Acylguanidine derivative
08/14/2008WO2008096777A1 Therapeutic agent for irritable bowel syndrome
08/14/2008WO2008096775A1 Therapeutic agent for pain disease
08/14/2008WO2008096769A1 Pharmaceutical compositions containing substituted cercosporamide derivatives
08/14/2008WO2008096755A1 Vanilloid receptor (vr1) inhibitor and use thereof
08/14/2008WO2008096746A1 Spiro compound and use thereof
08/14/2008WO2008096730A1 Anti-inflammatory agent and use thereof
08/14/2008WO2008096722A1 Agent for preventing bleeding from cerebral cortical vein
08/14/2008WO2008096690A1 Polyethylene glycol derivative
08/14/2008WO2008096586A1 Novel methylated catechin and composition containing the same
08/14/2008WO2008096547A1 Anti-tumor composition comprising tissue-accumulating chitosan gel
08/14/2008WO2008096377A2 Stable atorvastatin formulations
08/14/2008WO2008096369A2 Pharmaceutical formulation for use in hiv therapy
08/14/2008WO2008096351A1 Pharmaceutical compositions based on a microemulsion
08/14/2008WO2008096260A1 3-amino-pyrrolo[3,4-c] pyrazole- 5 (1h, 4h, 6h) carbaldehyde derivatives as pkc inhibitors
08/14/2008WO2008096218A1 2-amin0-5, 7-dihydr0-6h- pyrrolo [3, 4-d] pyrimidine derivatives as hsp-90 inhibitors for treating cancer
08/14/2008WO2008096201A2 Wicking quick-dry anti-microbial towel
08/14/2008WO2008096200A2 Purifier device for burnt gases from internal combustion engines
08/14/2008WO2008096155A1 Composition comprising a glycolytic inhibitor and a ring system comprising a sulphamate group for the treatment of cancer
08/14/2008WO2008096151A1 Pharmaceutical compositions of cb1 modulators
08/14/2008WO2008096149A2 Napadisylate salt of a muscarinic m3 antagonist
08/14/2008WO2008096143A1 Napadisylate salt of a muscarinic m3 antagonist
08/14/2008WO2008096136A1 Combinations with a muscarinic receptor antagonist
08/14/2008WO2008096129A1 Nitrogen containing hetrocyclic compounds useful as bifunctional modulators of m3 receptors and beta- 2 receptors
08/14/2008WO2008096128A1 Oxazole and thiazole derivatives and their uses 2
08/14/2008WO2008096126A1 Combination of a muscarinic receptor antagonist and a beta-2-adrenoceptor agonist
08/14/2008WO2008096122A2 Progesterone for the prevention of preterm birth
08/14/2008WO2008096121A1 Combinations of beta-2-adrenoceptor agonistic benzothiazolone
08/14/2008WO2008096119A1 Salts 669
08/14/2008WO2008096112A1 Salts 668
08/14/2008WO2008096111A1 Combinations of beta- 2 -adrenoceptor agonistic benzothiazolone
08/14/2008WO2008096094A1 Bicyclor[2.2.1]hept-7-ylamine derivatives as muscarinic m3 receptor modulators
08/14/2008WO2008096093A1 Oxazole and thiazole derivatives and their uses
08/14/2008WO2008096081A2 Use of riluzole and derivatives thereof for producing new drugs
08/14/2008WO2008096046A1 Noroxymorphone for use as a medicament
08/14/2008WO2008096028A1 Glycosylate derivatives of mithramycin, method of preparation and uses thereof
08/14/2008WO2008096021A2 Process for continuous production of lovastatine
08/14/2008WO2008096002A1 Hcv inhibiting macrocyclic phosphonates and amidophosphates
08/14/2008WO2008096001A1 Hcv inhibiting macrocyclic phenylcarbamates
08/14/2008WO2008095993A1 Novel nucleoside analogs for treatment of viral infections
08/14/2008WO2008095964A1 Crystalline form of moxifloxacin base
08/14/2008WO2008095944A1 7-azaindole derivatives and their use in the inhibition of c-jun n-terminal kinase
1 ... 3130 3131 3132 3133 3134 3135 3136 3137 3138 3139 3140 3141 3142 3143 3144 3145 3146 3147 3148 3149 3150 ... 7860